Search Results - "Wolinsky JS"

This result is not displayed to guests.
Login for full access.

Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS.

Authors: Arnold DL Kolind S Assemlal HE et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2025 Jun; Vol. 31 (7), pp. 821-832. Date of Electronic Publication: 2025 Apr 16.

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Perivascular space volume measurement at the inferior basal ganglia on cranial ultrasound in neonates: associations with germinal matrix hemorrhage and brain maturation.

Authors: Oh, Se Won Choi, Arum Bak, Dayeon et al.

Source: Ultrasonography. May2026, Vol. 45 Issue 3, p264-273. 10p.

Objective quality assessment of medical images and videos: review and challenges.

Authors: Rodrigues, Rafael Lévêque, Lucie Gutiérrez, Jesús et al.

Source: Multimedia Tools & Applications; Jul2025, Vol. 84 Issue 25, p29915-29948, 34p

Evaluation of a deep learning segmentation tool to help detect spinal cord lesions from combined T2 and STIR acquisitions in people with multiple sclerosis.

Authors: Lodé, Baptiste Hussein, Burhan Rashid Meurée, Cédric et al.

Source: European Radiology. Oct2025, Vol. 35 Issue 10, p5954-5964. 11p.

Subjects: Deep learning, Multiple sclerosis, Spinal cord tumors, Sensitivity analysis, Medical equipment, Inter-observer reliability

Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectiveness.

Authors: Silva, Berenice A. Heriz, Alejandra Ayerbe, Jeremías et al.

Source: Neurological Sciences. Dec2024, Vol. 45 Issue 12, p5841-5848. 8p.

Subjects: Learning curve, Drug efficacy, Demographic characteristics, Disease duration, Multiple sclerosis

Diffuse white matter pathology in multiple sclerosis during treatment with dimethyl fumarate—An observational study of changes in normal-appearing white matter using proton magnetic resonance spectroscopy.

Authors: Tisell, Anders Söderberg, Kristina Link, Yumin et al.

Source: PLoS ONE. 10/21/2024, Vol. 19 Issue 10, p1-18. 18p.

A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis.

Authors: Iaffaldano, Pietro Lucisano, Giuseppe Guerra, Tommaso et al.

Source: Annals of Clinical & Translational Neurology. Aug2024, Vol. 11 Issue 8, p2008-2015. 8p.

Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosis.

Authors: Ingvarsson, Jens Grut, Viktor Biström, Martin et al.

Source: Clinical & Translational Immunology. Apr2026, Vol. 15 Issue 4, p1-10. 10p.

Anti CD20 induced hypogammaglobulinemia in multiple sclerosis and neuromyelitis optica spectrum disorder: a cross sectional study.

Authors: ElGarhy, Ibrahim Nassef, Ayman Mohamed Ahmed Fouad, Mohamed Mahmoud et al.

Source: Egyptian Journal of Neurology, Psychiatry & Neurosurgery. 3/25/2026, Vol. 62 Issue 1, p1-7. 7p.

Novel Finding of Retinal Aneurysmal Alterations in Patients Undergoing Fingolimod Therapy for Multiple Sclerosis.

Authors: Menna, Feliciana Barbano, Lucilla Dell'Aquila, Carmen et al.

Source: Neurology & Therapy. Feb2026, Vol. 15 Issue 1, p435-445. 11p.

Early and active treatment with fingolimod for pediatric onset multiple sclerosis: the experience of an Italian pediatric center over the past 3 years.

Authors: Canavese C Borgogno M Gallo G et al.

Source: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2025 Aug; Vol. 46 (8), pp. 3803-3811. Date of Electronic Publication: 2025 Apr 02.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100959175 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1590-3478 (Electronic) Linking ISSN: 15901874 NLM ISO Abbreviation: Neurol Sci Subsets: MEDLINE

Multiple sclerosis classification and segmentation in neuroimaging MRI using different machine and deep learning techniques: a review.

Authors: Thabet, Rezq Muhammed Shedeed, Howida A. Al-Berry, Maryam et al.

Source: Artificial Intelligence Review; Aug2025, Vol. 58 Issue 8, p1-49, 49p

Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older Patients.

Authors: Alroughani, Raed Inshasi, Jihad Farouk, Samar et al.

Source: Neurology & Therapy. Aug2025, Vol. 14 Issue 4, p1169-1184. 16p.

The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry.

Authors: Braune, Stefan Bluemich, Sandra Bruns, Carola et al.

Source: BMC Neurology. 7/5/2023, Vol. 23 Issue 1, p1-12. 12p.

Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold.

Authors: Bsteh, Gabriel Hegen, Harald Krajnc, Nik et al.

Source: Annals of Clinical & Translational Neurology. Feb2025, Vol. 12 Issue 2, p345-354. 10p.

Development of mumps virus-specific sialidase imaging probes through chemical modifications of sialic acid.

Authors: Narimichi, Yutaka Takahashi, Tadanobu Kurebayashi, Yuuki et al.

Source: Scientific Reports. 11/25/2025, Vol. 15 Issue 1, p1-14. 14p.

Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis.

Authors: Young, Carolyn A. Rog, David J. Sharrack, Basil et al.

Source: Neurological Sciences. May2024, Vol. 45 Issue 5, p2181-2189. 9p.

Subjects: Multiple sclerosis, Disease relapse, Cancer fatigue, Smoking cessation, Neuralgia

Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study.

Authors: Montalban X Piasecka-Stryczynska K Kuhle J et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Apr; Vol. 30 (4-5), pp. 558-570. Date of Electronic Publication: 2024 Mar 04.

Publication Type: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.

Authors: Meca-Lallana, José E. Prieto González, José M. Caminero Rodríguez, Ana B. et al.

Source: Neurology & Therapy. Dec2023, Vol. 12 Issue 6, p2177-2193. 17p.